Skip Nav Destination
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi
Neurocognitive gains among Ugandan children with sickle cell anemia on hydroxyurea: 18-month interim trial results
The impact of CMV reactivation on mortality after chimeric antigen receptor T-cell therapy
Issue Archive
June 24 2025
In this Issue
Table of Contents
INSIDE BLOOD ADVANCES
REVIEW ARTICLES
CLINICAL TRIALS AND OBSERVATIONS
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi
Clinical Trials & Observations
Rexhep Durmo,Stephane Chauvie,Federico Fallanca,Fabrizio Bergesio,Antonio Pinto,Ilaria Del Giudice,Marta Coscia,Paolo Corradini,Emanuele Angelucci,Patrizia Tosi,Roberto Freilone,Filippo Ballerini,Alessia Bari,Domenico Pastore,Pier Luigi Zinzani,Silvia Bolis,Leonardo Flenghi,Arcangelo Liso,Jacopo Olivieri,Luigi Marcheselli,Michele Merli,Annibale Versari,Luca Guerra,Stefano Luminari
Neurocognitive gains among Ugandan children with sickle cell anemia on hydroxyurea: 18-month interim trial results
Clinical Trials & Observations
Global Advances
Shubaya K. Naggayi,Dennis Kalibbala,Vincent Mboizi,John Ssenkusu,Zhezhen Jin,Caterina Rosano,Deogratias Munube,Bill Wambaka,Ruth Namazzi,Phillip Kasirye,Maxencia Kabatabaazi,Grace Nambatya,Susan Murungi,Catherine Nabaggala,Maria Nakafeero,Ian R. Troidl,Robert Opoka,Richard Idro,Paul Bangirana,Nancy S. Green
HEALTH SERVICES AND OUTCOMES
IMMUNOBIOLOGY AND IMMUNOTHERAPY
CD19.CAR T-cell–derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy
Paola Lanuti,Francesco Guardalupi,Giulia Corradi,Rosalba Florio,Davide Brocco,Serena Veschi,Elsa Pennese,Domenico De Bellis,Francesca D’Ascanio,Anna Piro,Laura De Lellis,Pasquale Simeone,Maria Concetta Cufaro,Serena Pilato,Isabella D’Amario,Ida Villanova,Barbara Di Francesco,Lucia Di Re,Fabio Verginelli,Damiana Pieragostino,Prassede Salutari,Fabrizia Colasante,Annalisa Natale,Maria Vittoria Mattoli,Simone Vespa,Antonella Fontana,Raffaella Giancola,Bianca Fabi,Stefano Baldoni,Stella Santarone,Francesco Restuccia,Nicola Tinari,Piero Del Boccio,Alessandro Cama,Mauro Di Ianni
LYMPHOID NEOPLASIA
The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential
Miriam Verdú-Bou,Maria Joao Baptista,Marcelo Lima Ribeiro,Aleix Méndez-López,Núria Profitós-Pelejà,Fabian Frontzek,Gaël Roué,José Luís Mate,Mireia Pellicer,Pau Abrisqueta,Josep Castellví,Mariana Bastos-Oreiro,Javier Menárguez,Miguel Alcoceba,Eva González-Barca,Fina Climent,Antonio Salar,Juan-Manuel Sancho,Annette M. Staiger,German Ott,Ioannis Anagnostopoulos,Manel Esteller,Georg Lenz,Gustavo Tapia,José-Tomás Navarro
MYELOID NEOPLASIA
Distinct routes of clonal progression in SF3B1-mutant myelodysplastic syndromes
Martina Sarchi,Courtnee A. Clough,Anna Gallì,Cristina Picone,Beatrice Ferrari,Edie I. Crosse,Laura D. Baquero Galvis,Claudia Fiducioso,Nelli Aydinyan,J. Philip Creamer,Sara Pozzi,Elisabetta Molteni,Chiara Elena,Robert K. Bradley,Luca Malcovati,Sergei Doulatov
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSFUSION MEDICINE
TRANSPLANTATION
AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling
Alexander Zähringer,Inês Morgado,Daniel Erny,Florian Ingelfinger,Jana Gawron,Sangya Chatterjee,Valentin Wenger,Dominik Schmidt,Lennard Schwöbel,Rachael C. Adams,Marlene Langenbach,Alina Hartmann,Natascha Osswald,Julian Wolf,Günther Schlunck,Priscilla S. Briquez,Kathleen Grueter,Dietrich A. Ruess,Ian Frew,Ann-Cathrin Burk,Verena Holzmüller,Bodo Grimbacher,David Michonneau,Geoffroy Andrieux,Gérard Socié,Julia Kolter,Melanie Boerries,Marie Follo,Franziska Blaeschke,Lisa Sevenich,Marco Prinz,Robert Zeiser,Janaki Manoja Vinnakota
VASCULAR BIOLOGY
Endothelial cell activation enhances thromboinflammation in vaccine-induced immune thrombotic thrombocytopenia
Alexander Dupuy,Xiaoming Liu,Yvonne Kong,Miao Qi,Jose Perdomo,Jemma Fenwick,Jessica Tieng,Bede Johnston,Qiyu Sara Shi,Mark Larance,Yingqi Zhang,Lining Arnold Ju,Paul Coleman,Jennifer Gamble,Elizabeth E. Gardiner,Mortimer Poncz,Huyen Tran,Vivien Chen,Freda H. Passam
RESEARCH LETTERS
The impact of CMV reactivation on mortality after chimeric antigen receptor T-cell therapy
Clinical Trials & Observations
Eleftheria Kampouri,Patrick Flaherty,Hu Xie,Mandeep K. Sekhon,Clementine Chalal,Terry L. Stevens-Ayers,Damian J. Green,Jordan Gauthier,Mazyar Shadman,Ailyn C. Pérez-Osorio,Keith R. Jerome,Wendy M. Leisenring,Michael J. Boeckh,Joshua A. Hill
COMMENTARY
RESPONSE
-
Cover Image
Cover Image
Immunostaining of human umbilical vein endothelial cells for spike protein (red) after incubation with ChAdOx1 nCOV-19 adenoviral vaccine for 16 hours. Nuclei were stained in blue. See the article by Dupuy et al.
Advertisement intended for health care professionals
Advertisement intended for health care professionals
Long-term data needed for SCD gene therapy